GENEVA, Oct. 30 -- APOLLO AP45 LIMITED filed a patent application (EP2026/061565) for “1 H-PYRAZOLO[4,3-D]PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER”. With publication no. WO/2026/224217, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/4439

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....